|
Current issue
Archive
Manuscripts accepted
About the journal
Editorial board
Abstracting and indexing
Contact
Instructions for authors
Ethical standards and procedures
Editorial System
Submit your Manuscript
 
|
2/2024
vol. 99 abstract:
Review paper
Revisiting copper and zinc in end-stage renal disease patients
Maha Abd Sahab
1
,
Basim Abd Al-Raheem
1
,
Khalid Farouk
2
,
Hussein Kadhem Al-Hakeim
1
,
Maha Abd Al-Sahab
3
Pediatr Pol 2024; 99 (2): 143-148
Online publish date: 2024/06/27
View
full text
Get citation
ENW EndNote
BIB JabRef, Mendeley
RIS Papers, Reference Manager, RefWorks, Zotero
AMA
APA
Chicago
Harvard
MLA
Vancouver
Numerous research projects have discovered how trace elements affect people with end-stage renal disease (ESRD). Thus, understanding the mechanism of action and the potential treatment options requires research into the chemical compounds that have an impact on the kidneys. Trace elements are components of metalloproteins and act as cofactors for numerous essential enzymes. Among the most important trace elements that affect renal function are zinc and copper. The newly published papers on changes in the effects of both trace element products in ESRD patients were studied, and the justifications gathered from earlier studies were compiled. This review’s findings suggest that changes in trace element levels worsen ESRD patients’ health condition by deepening kidney dysfunction, which has a negative impact on their health. The mechanism by which these effects occur is reviewed, and schemes were plotted in order to show a comprehensive view of the role of dysregulation of copper and zinc in ESRD patients.
keywords:
end stage renal diseases, trace elements, haemodialysis, copper, zinc |
POLSKI
